MAB3491100
Human VEGFR3/Flt-4 Antibody, R&D Systems™
Manufacturer: Fischer Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | MAB3491100-Each-of-1 | In Stock | ₹ 47,015.22 |
MAB3491100 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 47,015.22
GST (18%): ₹ 8,462.74
Total Price: ₹ 55,477.96
Antigen
VEGFR3/Flt-4
Classification
Monoclonal
Conjugate
Unconjugated
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias
EC 2.7.10, EC 2.7.10.1, Flt-4, FLT4, fms-related tyrosine kinase 4, LMPH1A, PCLFLT41, soluble VEGFR3 variant 1, soluble VEGFR3 variant 2, soluble VEGFR3 variant 3, Tyrosine-protein kinase receptor FLT4, vascular endothelial growth factor receptor 3, VEGF R3, VEGFR-3, VEGFR3Fms-like tyrosine kinase 4
Host Species
Mouse
Purification Method
Protein A or G purified from hybridoma culture supernatant
Regulatory Status
RUO
Gene ID (Entrez)
2324
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype
IgG1
Applications
Western Blot, Immunohistochemistry, Immunocytochemistry
Clone
54703
Dilution
Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL, Immunocytochemistry 8-25 ug/mL
Gene Accession No.
P35916
Gene Symbols
FLT4
Immunogen
Mouse myeloma cell line NS0-derived recombinant human VEGFR3/Flt-4, Tyr25-Ile776, Accession # P35916
Quantity
100 μg
Primary or Secondary
Primary
Test Specificity
Detects human VEGFR3/Flt-4 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 25-30% cross-reactivity with recombinant mouse VEGFR3 is observed and no cross-reactivity with recombinant human (rh) VEGFR1 or rhVEGFR2 is observed.
Target Species
Human
Form
Supernatant
Related Products
Description
- VEGFR3/Flt-4 Monoclonal specifically detects VEGFR3/Flt-4 in Human samples
- It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry.
Compare Similar Items
Show Difference
Antigen: VEGFR3/Flt-4
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias: EC 2.7.10, EC 2.7.10.1, Flt-4, FLT4, fms-related tyrosine kinase 4, LMPH1A, PCLFLT41, soluble VEGFR3 variant 1, soluble VEGFR3 variant 2, soluble VEGFR3 variant 3, Tyrosine-protein kinase receptor FLT4, vascular endothelial growth factor receptor 3, VEGF R3, VEGFR-3, VEGFR3Fms-like tyrosine kinase 4
Host Species: Mouse
Purification Method: Protein A or G purified from hybridoma culture supernatant
Regulatory Status: RUO
Gene ID (Entrez): 2324
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG1
Applications: Western Blot, Immunohistochemistry, Immunocytochemistry
Clone: 54703
Dilution: Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL, Immunocytochemistry 8-25 ug/mL
Gene Accession No.: P35916
Gene Symbols: FLT4
Immunogen: Mouse myeloma cell line NS0-derived recombinant human VEGFR3/Flt-4, Tyr25-Ile776, Accession # P35916
Quantity: 100 μg
Primary or Secondary: Primary
Test Specificity: Detects human VEGFR3/Flt-4 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 25-30% cross-reactivity with recombinant mouse VEGFR3 is observed and no cross-reactivity with recombinant human (rh) VEGFR1 or rhVEGFR2 is observed.
Target Species: Human
Form: Supernatant
Antigen:
VEGFR3/Flt-4
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias:
EC 2.7.10, EC 2.7.10.1, Flt-4, FLT4, fms-related tyrosine kinase 4, LMPH1A, PCLFLT41, soluble VEGFR3 variant 1, soluble VEGFR3 variant 2, soluble VEGFR3 variant 3, Tyrosine-protein kinase receptor FLT4, vascular endothelial growth factor receptor 3, VEGF R3, VEGFR-3, VEGFR3Fms-like tyrosine kinase 4
Host Species:
Mouse
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Regulatory Status:
RUO
Gene ID (Entrez):
2324
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG1
Applications:
Western Blot, Immunohistochemistry, Immunocytochemistry
Clone:
54703
Dilution:
Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL, Immunocytochemistry 8-25 ug/mL
Gene Accession No.:
P35916
Gene Symbols:
FLT4
Immunogen:
Mouse myeloma cell line NS0-derived recombinant human VEGFR3/Flt-4, Tyr25-Ile776, Accession # P35916
Quantity:
100 μg
Primary or Secondary:
Primary
Test Specificity:
Detects human VEGFR3/Flt-4 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 25-30% cross-reactivity with recombinant mouse VEGFR3 is observed and no cross-reactivity with recombinant human (rh) VEGFR1 or rhVEGFR2 is observed.
Target Species:
Human
Form:
Supernatant
Antigen: VEGFR3/Flt-4
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias: EC 2.7.10, EC 2.7.10.1, Flt-4, FLT4, fms-related tyrosine kinase 4, LMPH1A, PCLFLT41, soluble VEGFR3 variant 1, soluble VEGFR3 variant 2, soluble VEGFR3 variant 3, Tyrosine-protein kinase receptor FLT4, vascular endothelial growth factor receptor 3, VEGF R3, VEGFR-3, VEGFR3Fms-like tyrosine kinase 4
Host Species: Mouse
Purification Method: Protein A or G purified from hybridoma culture supernatant
Regulatory Status: RUO
Gene ID (Entrez): 2324
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG1
Applications: Western Blot, Immunohistochemistry, Immunocytochemistry
Clone: 54703
Dilution: Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL, Immunocytochemistry 8-25 ug/mL
Gene Accession No.: P35916
Gene Symbols: FLT4
Immunogen: Mouse myeloma cell line NS0-derived recombinant human VEGFR3/Flt-4, Tyr25-Ile776, Accession # P35916
Quantity: 500 μg
Primary or Secondary: Primary
Test Specificity: Detects human VEGFR3/Flt-4 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 25-30% cross-reactivity with recombinant mouse VEGFR3 is observed and no cross-reactivity with recombinant human (rh) VEGFR1 or rhVEGFR2 is observed.
Target Species: Human
Form: Supernatant
Antigen:
VEGFR3/Flt-4
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias:
EC 2.7.10, EC 2.7.10.1, Flt-4, FLT4, fms-related tyrosine kinase 4, LMPH1A, PCLFLT41, soluble VEGFR3 variant 1, soluble VEGFR3 variant 2, soluble VEGFR3 variant 3, Tyrosine-protein kinase receptor FLT4, vascular endothelial growth factor receptor 3, VEGF R3, VEGFR-3, VEGFR3Fms-like tyrosine kinase 4
Host Species:
Mouse
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Regulatory Status:
RUO
Gene ID (Entrez):
2324
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG1
Applications:
Western Blot, Immunohistochemistry, Immunocytochemistry
Clone:
54703
Dilution:
Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL, Immunocytochemistry 8-25 ug/mL
Gene Accession No.:
P35916
Gene Symbols:
FLT4
Immunogen:
Mouse myeloma cell line NS0-derived recombinant human VEGFR3/Flt-4, Tyr25-Ile776, Accession # P35916
Quantity:
500 μg
Primary or Secondary:
Primary
Test Specificity:
Detects human VEGFR3/Flt-4 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 25-30% cross-reactivity with recombinant mouse VEGFR3 is observed and no cross-reactivity with recombinant human (rh) VEGFR1 or rhVEGFR2 is observed.
Target Species:
Human
Form:
Supernatant
Antigen: VEGFR3/Flt-4
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias: EC 2.7.10, EC 2.7.10.1, Flt-4, FLT4, fms-related tyrosine kinase 4, LMPH1A, PCLFLT41, soluble VEGFR3 variant 1, soluble VEGFR3 variant 2, soluble VEGFR3 variant 3, Tyrosine-protein kinase receptor FLT4, vascular endothelial growth factor receptor 3, VEGF R3, VEGFR-3, VEGFR3Fms-like tyrosine kinase 4
Host Species: Mouse
Purification Method: Protein A or G purified from hybridoma culture supernatant
Regulatory Status: RUO
Gene ID (Entrez): 2324
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG1
Applications: Western Blot, Immunohistochemistry, Immunocytochemistry
Clone: 54703
Dilution: Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL, Immunocytochemistry 8-25 ug/mL
Gene Accession No.: P35916
Gene Symbols: FLT4
Immunogen: Mouse myeloma cell line NS0-derived recombinant human VEGFR3/Flt-4, Tyr25-Ile776, Accession # P35916
Quantity: 25 μg
Primary or Secondary: Primary
Test Specificity: Detects human VEGFR3/Flt-4 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 25-30% cross-reactivity with recombinant mouse VEGFR3 is observed and no cross-reactivity with recombinant human (rh) VEGFR1 or rhVEGFR2 is observed.
Target Species: Human
Form: Purified
Antigen:
VEGFR3/Flt-4
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias:
EC 2.7.10, EC 2.7.10.1, Flt-4, FLT4, fms-related tyrosine kinase 4, LMPH1A, PCLFLT41, soluble VEGFR3 variant 1, soluble VEGFR3 variant 2, soluble VEGFR3 variant 3, Tyrosine-protein kinase receptor FLT4, vascular endothelial growth factor receptor 3, VEGF R3, VEGFR-3, VEGFR3Fms-like tyrosine kinase 4
Host Species:
Mouse
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Regulatory Status:
RUO
Gene ID (Entrez):
2324
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG1
Applications:
Western Blot, Immunohistochemistry, Immunocytochemistry
Clone:
54703
Dilution:
Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL, Immunocytochemistry 8-25 ug/mL
Gene Accession No.:
P35916
Gene Symbols:
FLT4
Immunogen:
Mouse myeloma cell line NS0-derived recombinant human VEGFR3/Flt-4, Tyr25-Ile776, Accession # P35916
Quantity:
25 μg
Primary or Secondary:
Primary
Test Specificity:
Detects human VEGFR3/Flt-4 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 25-30% cross-reactivity with recombinant mouse VEGFR3 is observed and no cross-reactivity with recombinant human (rh) VEGFR1 or rhVEGFR2 is observed.
Target Species:
Human
Form:
Purified
Antigen: Tau
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias: DDPAC, FLJ31424, FTDP-17, G protein beta1/gamma2 subunit-interacting factor 1, MAPT, MGC138549, microtubule-associated protein tau, MSTD, MSTDMAPTL, MTBT1, MTBT1Neurofibrillary tangle protein, MTBT2, Neurofibrillary tangle protein, PHF-tau, PPND, tau, TAUPaired helical filament-tau
Host Species: Mouse
Purification Method: Protein A or G purified from hybridoma culture supernatant
Regulatory Status: RUO
Gene ID (Entrez): 4137
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG1
Applications: Western Blot, Immunohistochemistry
Clone: 376720
Dilution: Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL
Gene Accession No.: P10636
Gene Symbols: MAPT
Immunogen: E. coli-derived recombinant human Tau Gln624-Gln756 Accession # P10636
Quantity: 100 μg
Primary or Secondary: Primary
Test Specificity: Detects human Tau in direct ELISAs and Western blots.
Target Species: Multi-species
Form: Purified
Antigen:
Tau
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias:
DDPAC, FLJ31424, FTDP-17, G protein beta1/gamma2 subunit-interacting factor 1, MAPT, MGC138549, microtubule-associated protein tau, MSTD, MSTDMAPTL, MTBT1, MTBT1Neurofibrillary tangle protein, MTBT2, Neurofibrillary tangle protein, PHF-tau, PPND, tau, TAUPaired helical filament-tau
Host Species:
Mouse
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Regulatory Status:
RUO
Gene ID (Entrez):
4137
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG1
Applications:
Western Blot, Immunohistochemistry
Clone:
376720
Dilution:
Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL
Gene Accession No.:
P10636
Gene Symbols:
MAPT
Immunogen:
E. coli-derived recombinant human Tau Gln624-Gln756 Accession # P10636
Quantity:
100 μg
Primary or Secondary:
Primary
Test Specificity:
Detects human Tau in direct ELISAs and Western blots.
Target Species:
Multi-species
Form:
Purified